Etoposide-related secondary acute myeloid leukemia (t-AML) in hemophagocytic lymphohistiocytosis

被引：16
作者：
Imashuku, Shinsaku [1 ]
机构：
[1] Tagasago Seibu Hosp, Div Pediat, Takasago, Hyogo 6760812, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2007年 / 48卷 / 02期
关键词：
D O I：
10.1002/pbc.21082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：121 / 123
页数：3
相关论文
共 20 条
[1]   Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation [J].
Henter, JI ;
Samuelsson-Horne, A ;
Aricò, M ;
Egeler, RM ;
Elinder, G ;
Filipovich, AH ;
Gadner, H ;
Imashuku, S ;
Komp, D ;
Ladisch, S ;
Webb, D ;
Janka, G .
BLOOD, 2002, 100 (07) :2367-2373
[2]   MYELODYSPLASTIC SYNDROME FOLLOWING EPIPODOPHYLLOTOXIN THERAPY IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS [J].
HENTER, JI ;
ELINDER, G ;
LUBECK, PO ;
OST, A .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1993, 10 (02) :163-168
[3]   Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis [J].
Imashuku, S ;
Kuriyama, K ;
Teramura, T ;
Ishii, E ;
Kinugawa, N ;
Kato, M ;
Sako, M ;
Hibi, S .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2665-2673
[4]   Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) [J].
Imashuku, S ;
Tabata, Y ;
Teramura, T ;
Hibi, S .
LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) :37-49
[5]   Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: A report from the HLH Study Center [J].
Imashuku, S ;
Kuriyama, K ;
Sakai, R ;
Nakao, Y ;
Masuda, SI ;
Yasuda, N ;
Kawano, F ;
Yakushijin, K ;
Miyagawa, A ;
Nakao, T ;
Teramura, T ;
Tabata, Y ;
Morimoto, A ;
Hibi, S .
MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (02) :103-109
[6]   Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis [J].
Imashuku, S ;
Teramura, T ;
Kuriyama, K ;
Kitazawa, J ;
Ito, E ;
Morimoto, A ;
Hibi, S .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (02) :174-177
[7]   Modern management of children with haemophagocytic lymphohistiocytosis [J].
Janka, GE ;
Schneider, EM .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) :4-14
[8]   Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis [J].
Kitazawa, J ;
Ito, E ;
Arai, K ;
Yokoyama, M ;
Fukayama, M ;
Imashuku, S .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (02) :153-154
[9]   High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults [J].
Le Deley, MC ;
Vassal, G ;
Taïbi, A ;
Shamsaldin, A ;
Leblanc, T ;
Hartmann, O .
PEDIATRIC BLOOD & CANCER, 2005, 45 (01) :25-31
[10]   Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis [J].
Ng, A ;
Ravetto, PF ;
Taylor, GM ;
Wynn, RF ;
Eden, OB .
BRITISH JOURNAL OF CANCER, 2004, 91 (12) :1990-1992
12